Brown & Brown shares slide as investors weigh flat organic growth and near-term integration headwinds

Brown & Brown, Inc. (BRO) is down 4.4% today. Here is some analysis on what might have caused this price movement.

Analysis: The drop appears tied to the market’s reaction to Brown & Brown’s latest quarterly update, where reported revenue jumped largely on acquisitions but underlying organic revenue was flat. Investors also seemed focused on softer GAAP earnings and commentary implying a slower near-term growth profile in parts of the business while the company integrates its large Accession acquisition.

Details:

Brown & Brown’s first-quarter 2026 release showed total revenue of $1.9 billion (+35.4% year over year), but organic revenue was flat (2.2% when including contingents).

The company reported diluted net income per share of $1.06 (down from the prior year’s $1.15), while adjusted diluted EPS was $1.39.

Management highlighted ongoing Accession integration and acquisition-related items as notable factors within the quarter’s results and disclosures.

Separate coverage of the earnings call highlighted expectations for relatively flat organic growth in specialty distribution in Q2, which may have reinforced concerns about underlying momentum.

Sources:

Brown & Brown Investor Relations, U.S. SEC (EDGAR), The Insurer

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$BRO Hedge Fund Activity

We have seen 387 institutional investors add shares of $BRO stock to their portfolio, and 507 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CAPITAL INTERNATIONAL INVESTORS added 4,663,165 shares (+inf%) to their portfolio in Q4 2025, for an estimated $371,654,250
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 4,628,321 shares (-75.6%) from their portfolio in Q4 2025, for an estimated $368,877,183
SELECT EQUITY GROUP, L.P. added 3,358,403 shares (+55.3%) to their portfolio in Q4 2025, for an estimated $267,664,719
VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. added 2,589,048 shares (+132.8%) to their portfolio in Q4 2025, for an estimated $206,347,125
NORGES BANK added 2,572,629 shares (+65.8%) to their portfolio in Q4 2025, for an estimated $205,038,531
BOSTON PARTNERS removed 1,570,698 shares (-98.9%) from their portfolio in Q4 2025, for an estimated $125,184,630
ROYAL BANK OF CANADA removed 1,491,211 shares (-30.5%) from their portfolio in Q4 2025, for an estimated $118,849,516

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.

$BRO Congressional Stock Trading

Members of Congress have traded $BRO stock 14 times in the past 6 months. Of those trades, 6 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $BRO stock by members of Congress over the last 6 months:

REPRESENTATIVE JARED MOSKOWITZ has traded it 3 times. They made 0 purchases and 3 sales worth up to $45,000 on 03/23.
REPRESENTATIVE BYRON DONALDS has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 02/10.
REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 5 times. They made 5 purchases worth up to $75,000 on 02/06, 12/12, 12/05, 11/20, 10/31 and 0 sales.
REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 2 times. They made 1 purchase worth up to $15,000 on 11/18 and 1 sale worth up to $15,000 on 01/09.
REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 12/11.
REPRESENTATIVE LISA C. MCCLAIN sold up to $15,000 on 10/31.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API.

$BRO Analyst Ratings

Wall Street analysts have issued reports on $BRO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Truist Securities issued a "Buy" rating on 01/15/2026

To track analyst ratings and price targets for $BRO, check out Quiver Quantitative's $BRO forecast page.

$BRO Price Targets

Multiple analysts have issued price targets for $BRO recently. We have seen 15 analysts offer price targets for $BRO in the last 6 months, with a median target of $81.0.

Here are some recent targets:

Meyer Shields from Keefe, Bruyette & Woods set a target price of $72.0 on 04/29/2026
Rowland Mayor from RBC Capital set a target price of $72.0 on 04/29/2026
Mark Hughes from Truist Securities set a target price of $90.0 on 04/29/2026
Elyse Greenspan from Wells Fargo set a target price of $69.0 on 04/29/2026
Joshua Shanker from B of A Securities set a target price of $88.0 on 04/14/2026
Yaron Kinar from Mizuho set a target price of $84.0 on 04/13/2026
Pablo Singzon from JP Morgan set a target price of $85.0 on 04/09/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.